SEC Form 4 · accession 0001209191-15-048255
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Geraghty
Director
Period of report
May 26, 2015
Accepted (ET)
Jun 1, 2015 · 2:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| $0.01 par value RSA - Common Stock | May 26, 2015 | A | 461 | $7.51 | A | 461 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $7.51 | May 26, 2015 | A | 70,000 | A | Aug 26, 2016 | May 26, 2022 | $0.01 par value of common stock | 70,000 | 70,000 | D |
Explanation of responses
- F1The option will become exercisable in 8.33% increments of the shares on every 3 month anniversary from the grant date
Remarks
The $0.01 par value RSA - Common Stock will fully vest at the 2015 Annual Shareholders Meeting